Patents Assigned to Bioo Scientific Corporation
  • Patent number: 11970786
    Abstract: The disclosed methods and kits are useful in processing and analyzing a multiplicity of samples in molecular biology workflows where there is an increased chance for sample cross-contamination or misidentification. Some embodiments of the methods and kits utilize at least one spike in control and at least one barcode per sample.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: April 30, 2024
    Assignee: BIOO Scientific Corporation
    Inventors: Shannon Piehl, Josh Kinman
  • Patent number: 11441175
    Abstract: Methods and kits for depleting amplicons that correspond to undesired RNA species present in a sample are provided. The disclosed methods and kits employ a blocker that anneals with at least a portion of the undesired RNA, resulting in a duplex that is not a suitable substrate for ligating an adapter to the end of the undesired RNA.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: September 13, 2022
    Assignee: BIOO Scientific Corporation
    Inventors: Suk Ho Eun, Adam Morris
  • Patent number: 11401543
    Abstract: The invention generally relates to compositions for maximizing capture of affinity-labeled molecules on solid supports. The disclosed methods and compositions were developed to maximize depletion of ribosomal RNA from total RNA samples, which is useful to improve the quality of RNA preparations used for applications such as massively parallel sequencing. The RNA depletion method is based on using long affinity-labeled RNA molecules that are complementary to all or part of the target ribosomal RNAs, as subtractive hybridization probes.
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: August 2, 2022
    Assignee: BIOO Scientific Corporation
    Inventors: Marianna Goldrick, Lance Lepovitz, Masoud Toloue
  • Patent number: 11326160
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise reverse transcribing mRNA to produce DNA:mRNA hybrids, treating the DNA:mRNA hybrids with RNAseH to produce mRNA fragments, and reverse transcribing the mRNA fragments.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: May 10, 2022
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Adam Morris
  • Patent number: 11104941
    Abstract: This disclosure provides, among other things, a 5? adapter of the formula 3?*—X—(5?5?)—Y—3?, where: 3?* is a blocked 3? end, X is a synthetic sequence, (5?5?) is an internal 5?-5? linkage, Y is an adapter sequence, and 3? is a hydroxylated 3? end. In use, sequence X hybridizes to sequence X? in a population of RNA molecules of formula R—X?, which increases the efficiency of ligation of the 5? adapter to the nucleic acid molecules.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: August 31, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Suk Ho Eun
  • Patent number: 10954542
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise adding a polyA tail to the longer RNA fragments but not the shorter RNA fragments in a sample by incubating the population of RNA fragments with a polyA polymerase, wherein the reaction conditions used preferentially tail only the longer fragments but not the shorter fragments.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: March 23, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventor: Kevin Allen
  • Patent number: 10894978
    Abstract: A method for amplifying a CYP21A2 gene and/or a CYP21A2 gene chimera from a sample is provided. In some embodiments, the method may comprise amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in a bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene. Methods for analyzing the amplification product are also provided.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: January 19, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Colby Clear, Radmila Hrdlickova, Jiri Nehyba, Dylan Fox
  • Patent number: 10871484
    Abstract: Polyaromatic hydrocarbons (PAH) from industrial waste and oil spills are a recurrent threat to food safety due to their stability and toxicity. Existing methods to establish the concentrations of PAH in environmental and food samples rely on expensive and laborious methodology. The teachings herein provide methods and kits for detecting the presence or absence of PAH. In certain embodiments, the quantity of PAH in a sample can be determined.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: December 22, 2020
    Assignee: BIOO Scientific Corporation
    Inventors: Nicolas M. Kosa, Joseph F. Krebs, Darshan N. Kasal
  • Patent number: 10711271
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise reverse transcribing mRNA to produce DNA:mRNA hybrids, treating the DNA:mRNA hybrids with RNAseH to produce mRNA fragments, and reverse transcribing the mRNA fragments.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: July 14, 2020
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Kevin Allen, Adam Morris
  • Patent number: 10696994
    Abstract: This disclosure provides, among other things, a method for making a cDNA library. In some embodiments the method may comprise adding a polyA tail to the longer RNA fragments but not the shorter RNA fragments in a sample by incubating the population of RNA fragments with a polyA polymerase, wherein the reaction conditions used preferentially tail only the longer fragments but not the shorter fragments.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: June 30, 2020
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventor: Kevin Allen
  • Patent number: 10597706
    Abstract: The current teachings relate to methods for reducing adapter-dimer formation, particularly when preparing nucleic acids of interest for subsequent amplification and/or sequencing. Also described are kits for use in performing certain disclosed methods.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: March 24, 2020
    Assignee: BIOO Scientific Corporation
    Inventors: Masoud Toloue, Adam R. Morris, Kevin D. Allen
  • Patent number: 10550158
    Abstract: Anti-peptide antibodies (APAs) are extremely important tools for biomedical research. Many important techniques, such as immunoblots, ELISA immunoassays, immunocytochemistry, and protein microarrays are intrinsically linked to APA function and completely dependent on APA quality. Unfortunately, not all commercially-available APAs have good antigen binding characteristics; as a result, researchers are often unable to perform high quality protein analysis experiments. This disclosure describes a new method for the scalable production of polyclonal APAs using recombinant antigens. These recombinant peptide antigens have several advantages over traditional peptide antigens which improve the ease and speed of antibody production. The recombinant antigens can be scalably produced and purified much faster than traditional synthetic peptide-conjugates.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: February 4, 2020
    Assignee: BIOO Scientific Corporation
    Inventors: Joseph Krebs, Paul Morrison, Jun Wang
  • Patent number: 10364455
    Abstract: The invention generally relates to compositions for maximizing capture of affinity-labeled molecules on solid supports. The disclosed methods and compositions were developed to maximize depletion of ribosomal RNA from total RNA samples, which is useful to improve the quality of RNA preparations used for applications such as massively parallel sequencing. The RNA depletion method is based on using long affinity-labeled RNA molecules that are complementary to all or part of the target ribosomal RNAs, as subtractive hybridization probes.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: July 30, 2019
    Assignee: BIOO Scientific Corporation
    Inventors: Marianna Goldrick, Lance Lepovitz, Masoud Toloue
  • Publication number: 20180258477
    Abstract: Methods and kits for depleting amplicons that correspond to undesired RNA species present in a sample are provided. The disclosed methods and kits employ a blocker that anneals with at least a portion of the undesired RNA, resulting in a duplex that is not a suitable substrate for ligating an adapter to the end of the undesired RNA.
    Type: Application
    Filed: February 27, 2018
    Publication date: September 13, 2018
    Applicant: Bioo Scientific Corporation
    Inventors: Suk Ho Eun, Adam Morris
  • Patent number: 9745353
    Abstract: Anti-peptide antibodies (APAs) are extremely important tools for biomedical research. Many important techniques, such as immunoblots, ELISA immunoassays, immunocytochemistry, and protein microarrays are intrinsically linked to APA function and completely dependent on APA quality. Unfortunately, not all commercially-available APAs have good antigen binding characteristics; as a result, researchers are often unable to perform high quality protein analysis experiments. This disclosure describes a new method for the scalable production of polyclonal APAs using recombinant antigens. These recombinant peptide antigens have several advantages over traditional peptide antigens which improve the ease and speed of antibody production. The recombinant antigens can be scalably produced and purified much faster than traditional synthetic peptide-conjugates.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: August 29, 2017
    Assignee: Bioo Scientific Corporation
    Inventors: Joseph Krebs, Paul Morrison, Jun Wang
  • Patent number: 9255291
    Abstract: Described herein is a buffer concentration for highly efficient ligation of two oligonucleotides. The embodiments herein have led to the development of an optimized ligation step used in the sample preparation for sequencing reactions. Further, embodiments herein describe a high-throughput method for sequencing using barcodes or the purpose of multiplexing several samples simultaneously and novel methods for making targeted DNA libraries for re-sequencing on massively parallel next-generation sequencing platforms and for alternatives to gel-purification for recovering the desired templates from small RNA libraries for next generation sequencing.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: February 9, 2016
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Masoud M. Toloue, Marianna Goldrick
  • Patent number: 9127301
    Abstract: Described herein is a rapid coupled enzymatic assay to detect polycyclic aromatic hydrocarbon (PAH) compounds in samples. The method uses a detection composition that includes: a buffered solution comprising NADH; naphthalene dioxygenase, naphthalene 1,2-dihydroxy-1,2-dihydronaphthalene dehydrogenase, and 1,2-dihydroxynaphthalene dioxygenase. The presence of PAH is determined by noting a color change of the detection composition, either visually or spectrophotometrically.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: September 8, 2015
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Joseph F. Krebs, John Duvall-Jisha, Sol Resnick
  • Patent number: 8900627
    Abstract: This application describes emulsion formulations containing neutral phospholipids for delivering RNAi, anti-miRNA, or aptamer agents in vivo. The application also relates to methods of making the formulations, and uses of the formulations as delivery agents.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: December 2, 2014
    Assignees: Mirna Therapeutics, Inc., BIOO Scientific Corporation
    Inventors: Lance Ford, David Brown, Andreas G. Bader
  • Publication number: 20140342442
    Abstract: A method and sensor for detecting the presence of specific target nucleic acids uses a biosensor comprising an array of single stranded probe oligonucleotides, wherein one end of each probe oligonucleotide is linked to a label and the other end of each probe oligonucleotide is attached to an electrode of a solid support. The method includes determining the capacitance at one or more of the electrodes, where a change in the capacitance of the one or more electrodes indicates the presence of target nucleic acid complementary to the single stranded oligonucleotide probe.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 20, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventors: Masoud M. Toloue, Michael T. Mueller, Swapna Gone
  • Publication number: 20140295418
    Abstract: The invention generally relates to compositions for maximizing capture of affinity-labeled molecules on solid supports. The disclosed methods and compositions were developed to maximize depletion of ribosomal RNA from total RNA samples, which is useful to improve the quality of RNA preparations used for applications such as massively parallel sequencing. The RNA depletion method is based on using long affinity-labeled RNA molecules that are complementary to all or part of the target ribosomal RNAs, as subtractive hybridization probes.
    Type: Application
    Filed: September 27, 2013
    Publication date: October 2, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventors: Marianna Goldrick, Lance Lepovitz, Masoud Toloue